ANNA SPELTS

Allopathic & Osteopathic Physicians|Internal Medicine HINESVILLE, GA NPI 1679090856

General Payments — all program years on this page

$2,109.37

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 122
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $454.66 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $454.6622

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $197.1914
2022 $848.5450
2023 $608.9836
2024 $454.6622

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077992226 Janssen Pharmaceuticals, Inc $23.87 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092400944 Boston Scientific Corporation $37.16 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096567014 Novo Nordisk Inc $21.47 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096831061 Novo Nordisk Inc $16.49 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097492977 Novo Nordisk Inc $18.98 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097668302 Novo Nordisk Inc $13.54 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104330688 AstraZeneca Pharmaceuticals LP $31.85 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104374877 AstraZeneca Pharmaceuticals LP $13.07 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106145748 ABBVIE INC. $19.84 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106145750 ABBVIE INC. $16.99 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106145752 ABBVIE INC. $13.07 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106145754 ABBVIE INC. $20.48 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114912842 Exact Sciences Corporation $14.89 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116519142 GlaxoSmithKline, LLC. $18.76 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116537930 GlaxoSmithKline, LLC. $19.59 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117389224 Amgen Inc. $15.69 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135999639 Lilly USA, LLC $16.41 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136041724 Lilly USA, LLC $14.36 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136044994 Lilly USA, LLC $27.97 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141669712 Merck Sharp & Dohme LLC $23.60 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148114007 Inspire Medical Systems, Inc. $40.15 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281319 Dexcom, Inc. $16.43 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.